| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;44:210.)
© 2004 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pharmacology (J.-I.K., F.Z., Y.W., W.W, M.L.-S., A.N.), New York Medical College, Valhalla, and Department of Biochemistry and Pharmacology (V.R.G., J.R.F.), University of Texas Southwestern Medical School, Dallas.
Correspondence to Alberto Nasjletti, MD, Department of Pharmacology, New York Medical College, Valhalla, New York 10595. E-mail alberto_nasjletti{at}nymc.edu
We examined the influence of interactions between CO and 20-hydroxyeicosatetraenoic acid (20-HETE) on vascular reactivity to phenylephrine and vasopressin. Renal interlobar arteries incubated in Krebs buffer released CO at a rate that is decreased (from 125.0±15.2 to 46.3±8.8 pmol/mg protein per hour, P<0.05) by the heme oxygenase inhibitor chromium mesoporphyrin (CrMP; 30 µmol/L). The level of 20-HETE in vessels was not affected by CrMP (74.3±6.1 versus 72.5±16.2 pmol/mg protein), but was decreased (P<0.05) by CO (1 µmol/L; 33.2±7.9 pmol/mg protein) or the cytochrome P4504A inhibitor N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS; 30 µmol/L; 11.4±3.3 pmol/mg protein). Phenylephrine elicited development of isometric tension in vascular rings mounted on a wire-myograph (EC50, 0.29±0.02 µmol/L; Rmax, 3.78±0.19 mN/mm). The sensitivity to phenylephrine was decreased (P<0.05) by CO (1 µmol/L; EC50, 0.60±0.04 µmol/L) or DDMS (EC50, 0.71±0.12 µmol/L) and increased (P<0.05) by 20-HETE (10 µmol/L; EC50, 0.08±0.02 µmol/L) or CrMP (EC50, 0.11±0.02 µmol/L). Notably, neither CO nor CrMP changed the sensitivity to phenylephrine in vessels treated with DDMS. Refractoriness to CO and CrMP in such a setting was eliminated by inclusion of 20-HETE (1 µmol/L) in the bathing buffer. The aforementioned interventions affected the vascular reactivity to vasopressin in a similar manner. These data indicate that the reactivity of renal arteries to phenylephrine and vasopressin is reciprocally influenced by CO and 20-HETE of vascular origin and that CO desensitizes the vascular smooth muscle to constrictor agonists by interfering with the sensitizing influence of 20-HETE.
Key Words: adrenergic receptor agonists vasopressins potassium channels renal circulation
This article has been cited by other articles:
![]() |
D. E. Stec, H. A. Drummond, and T. Vera Role of Carbon Monoxide in Blood Pressure Regulation Hypertension, March 1, 2008; 51(3): 597 - 604. [Full Text] [PDF] |
||||
![]() |
K. A. Nath, L. V. d'Uscio, J. P. Juncos, A. J. Croatt, M. C. Manriquez, S. T. Pittock, and Z. S. Katusic An analysis of the DOCA-salt model of hypertension in HO-1-/- mice and the Gunn rat Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H333 - H342. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sarkis, O. Ito, T. Mori, M. Kohzuki, S. Ito, J. Verbalis, A. W. Cowley Jr., and R. J. Roman Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1333 - F1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mayer, W. Lieb, A. Gotz, I. R. Konig, Z. Aherrahrou, A. Thiemig, S. Holmer, C. Hengstenberg, A. Doering, H. Loewel, et al. Association of the T8590C Polymorphism of CYP4A11 With Hypertension in the MONICA Augsburg Echocardiographic Substudy Hypertension, October 1, 2005; 46(4): 766 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, H. Deng, R. Kemp, H. Singh, V. R. Gopal, J. R. Falck, M. Laniado-Schwartzman, and A. Nasjletti Decreased Levels of Cytochrome P450 2E1-Derived Eicosanoids Sensitize Renal Arteries to Constrictor Agonists in Spontaneously Hypertensive Rats Hypertension, January 1, 2005; 45(1): 103 - 108. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |